Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats

• Monica L. Fernández-Quintero,
• Patrick K. Quoika,
• Florian S. Wedl,
• Clarissa A. Seidler,
• Katharina B. Kroell,
• Johannes R. Loeffler,
• Nancy D. Pomarici,
• Valentin J. Hoerschinger,
• Alexander Bujotzek,
• Guy Georges,
• Hubert Kettenberger,
• Klaus R. Liedl

Affiliations

Monica L. Fernández-Quintero

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Patrick K. Quoika

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Florian S. Wedl

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Clarissa A. Seidler

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Katharina B. Kroell

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Johannes R. Loeffler

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Nancy D. Pomarici

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Valentin J. Hoerschinger

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria

Alexander Bujotzek

Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany

Guy Georges

Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany

Hubert Kettenberger

Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany

Klaus R. Liedl

Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria